Disc Medicine Sells $720k: CFO Moves After FDA Rejection
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Enhance your travels by using credit card points for exciting tours and activities. Discover how to make it happen!
28,655 articlesA biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Starting with $1,000? This hands-on guide shows you how to build a solid starter portfolio. Learn a practical mix of ...
Geopolitical risk around the Strait of Hormuz is flaring. This report examines which warships that could dominate Hor...
NVIDIA stock investors just received a wave of favorable headlines from Wall Street. Strong AI demand, rising price t...
A self-employed architect plans a four-bucket retirement strategy that shifts income across Roth, HSA, and pretax acc...
When a major investor's affiliate sells a stake in Coursera, it prompts questions about future growth and risk. This ...
Morgan Stanley publishes a comprehensive post-sale framework to help founders manage the emotional and financial tran...
In 2026, two very different healthcare players—Abbott Laboratories and Glaukos—offer contrasting paths to potential g...
AST SpaceMobile dropped about 13% in early trading after pricing a $1 billion convertible offering and signaling pote...
A confident march for Nvidia stock could hinge on one powerful trend. This article breaks down the single reason reas...
Regulators move toward a sweeping U.S. crypto framework, boosting risk assets and shaping near-term price moves. Bitc...
JPMorgan Chase CEO Jamie Dimon warned that U.S. defense procurement has shifted toward European-style bureaucracy, po...